MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 17 - per page Next page
Order by
25 and 50 mg diclofenac K film coated immediate release tablets More
The First Line of Therapy in Severe Migraine Attacks More
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
Locally applied and locally acting NSAID Matrix Patch containing 140 mg Diclofenac Sodium More
Novel Dual Chamber Dispenser with polycarbonate and stainless steel components for accurate Rx dosing. More
Anti-inflammatory drugs are commonly spread and used to treat pain, arthrosis, asthma or psoriasis. Our laboratory has developed a new molecule against these diseases with some interesting results. More
A method for reducing activity of inflammatory immune cells by exposure to selenium. Particularly, the invention relates to a method of short-term, high dose dietary selenium supplementation for treating a subject having an inflammatory disease,... More
Novel non-hydrolysable analogue of endogenous cannabinoids, which are found to be more potent therapeutic agents as they are more stable, for example, to hydrolytic cleavage in the gastrointestinal tract. Such compositions may be used as... More
cannabidiol (CBD) was found to b effective in reducing total area covered by artherosclerotic plaques (composed of the number and/or size of atherosclerotic plaques) in aortas and in lowering triglycerides, LDL and cholesterol levels in in-vivo... More
Displaying 1..10 of 17 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Pharmalicensing Jobs 1
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us